메뉴 건너뛰기




Volumn 132, Issue 35-36, 2002, Pages 517-522

Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996

Author keywords

Cohort analysis; Surveillance; Switzerland; Treatment outcome; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

EID: 0037037293     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (30)

References (17)
  • 1
    • 0004104929 scopus 로고    scopus 로고
    • Global tuberculosis control
    • WHO document; WHO/CDS/TB/2001
    • World Health Organization. Global tuberculosis control. WHO Report 2001. WHO document 2001; WHO/CDS/TB/2001.287:1-181.
    • (2001) WHO Report 2001 , vol.287 , pp. 1-181
  • 2
    • 0027336393 scopus 로고
    • When tuberculosis treatment fails. A social behavioral account of patient adherence
    • Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis 1993;147:1311-20.
    • (1993) Am Rev Respir Dis , vol.147 , pp. 1311-1320
    • Sumartojo, E.1
  • 3
    • 0031867849 scopus 로고    scopus 로고
    • Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients
    • Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M, Zalesky R. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998;12:505-10.
    • (1998) Eur Respir J , vol.12 , pp. 505-510
    • Veen, J.1    Raviglione, M.2    Rieder, H.L.3    Migliori, G.B.4    Graf, P.5    Grzemska, M.6    Zalesky, R.7
  • 4
    • 0011946139 scopus 로고    scopus 로고
    • Lignes directrices pour le traitement de la tuberculose
    • Association suisse contre la tuberculose et les maladies pulmonaires, Office fédéral de la santé publique. Lignes directrices pour le traitement de la tuberculose. Bulletin OFSP 1996;16:9-13.
    • (1996) Bulletin OFSP , vol.16 , pp. 9-13
  • 5
    • 0012005624 scopus 로고    scopus 로고
    • La tuberculose en Suisse en 1999 et 2000
    • Office fédéral de la santé publique. La tuberculose en Suisse en 1999 et 2000. Bulletin OFSP 2002;9:168-73.
    • (2002) Bulletin OFSP , vol.9 , pp. 168-173
  • 6
    • 0033885197 scopus 로고    scopus 로고
    • Surveillance of antituberculosis drug resistance in Switzerland 1995-1997: The central link
    • Helbling P, Altpeter E, Raeber PA, Pfyffer GE, Zellweger JP. Surveillance of antituberculosis drug resistance in Switzerland 1995-1997: The central link. Eur Respir J 2000;16:200-2.
    • (2000) Eur Respir J , vol.16 , pp. 200-202
    • Helbling, P.1    Altpeter, E.2    Raeber, P.A.3    Pfyffer, G.E.4    Zellweger, J.P.5
  • 8
    • 0032812259 scopus 로고    scopus 로고
    • Tuberculosis treatment in Denmark: Treatment outcome for all Danish patients in 1992
    • Lillebaek T, Poulsen S, Kok-Jensen A. Tuberculosis treatment in Denmark: treatment outcome for all Danish patients in 1992. Int J Tuberc Lung Dis 1999;3:603-12.
    • (1999) Int J Tuberc Lung Dis , vol.3 , pp. 603-612
    • Lillebaek, T.1    Poulsen, S.2    Kok-Jensen, A.3
  • 9
    • 0031745964 scopus 로고    scopus 로고
    • Mortality among tuberculosis patients in The Netherlands in the period 1993-1995
    • Borgdorff MW, Veen J, Kalisvaart NA, Nagelkerke N. Mortality among tuberculosis patients in The Netherlands in the period 1993-1995. Eur Respir J 1998;11:816-20.
    • (1998) Eur Respir J , vol.11 , pp. 816-820
    • Borgdorff, M.W.1    Veen, J.2    Kalisvaart, N.A.3    Nagelkerke, N.4
  • 10
    • 4243275150 scopus 로고    scopus 로고
    • Tuberculosis in the Canton of Zurich 1991-1993: Treatment results and influence of directly observed therapy (DOT)
    • Shang H, Rose N, Pfyffer G, Brändli O. Tuberculosis in the Canton of Zurich 1991-1993: Treatment results and influence of directly observed therapy (DOT). Schweiz Med Wochenschr 1996;126:16S.
    • (1996) Schweiz Med Wochenschr , vol.126
    • Shang, H.1    Rose, N.2    Pfyffer, G.3    Brändli, O.4
  • 11
    • 0031815108 scopus 로고    scopus 로고
    • Outcome of patients treated for tuberculosis in Vaud County, Switzerland
    • Zellweger JP, Coulon P. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis 1998;2:372-7.
    • (1998) Int J Tuberc Lung Dis , vol.2 , pp. 372-377
    • Zellweger, J.P.1    Coulon, P.2
  • 12
    • 0029898701 scopus 로고    scopus 로고
    • Surveillance of tuberculosis in Europe
    • Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases
    • Rieder HL, Watson JM, Raviglione MC, Forssbohm M, Migliori GB, et al. Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. Eur Respir J 1996;9:1097-104.
    • (1996) Eur Respir J , vol.9 , pp. 1097-1104
    • Rieder, H.L.1    Watson, J.M.2    Raviglione, M.C.3    Forssbohm, M.4    Migliori, G.B.5
  • 14
    • 0002215087 scopus 로고    scopus 로고
    • Therapieergebnisse bei der pulmonalen tuberkulose: Outcome-monitoring im nördlichen Niedersachsen
    • Menke B, Sommerwerck D, Schaberg T. Therapieergebnisse bei der pulmonalen Tuberkulose: Outcome-Monitoring im nördlichen Niedersachsen. [Results of therapy in pulmonary tuberculosis: outcome monitoring in northern Lower Saxony]. Pneumologie 2000;54:92-6.
    • (2000) Pneumologie , vol.54 , pp. 92-96
    • Menke, B.1    Sommerwerck, D.2    Schaberg, T.3
  • 15
    • 0033880848 scopus 로고    scopus 로고
    • Defaulting from tuberculosis treatment in The Netherlands: Rates, risk factors and trend in the period 1993-1997
    • Borgdorff MW, Veen J, Kalisvaart NA, Broekmans JF, Nagelkerke NJ. Defaulting from tuberculosis treatment in The Netherlands: Rates, risk factors and trend in the period 1993-1997. Eur Respir J 2000;16:209-13.
    • (2000) Eur Respir J , vol.16 , pp. 209-213
    • Borgdorff, M.W.1    Veen, J.2    Kalisvaart, N.A.3    Broekmans, J.F.4    Nagelkerke, N.J.5
  • 16
    • 0035040113 scopus 로고    scopus 로고
    • Is quarterly cohort analysis useful for assessing treatment outcomes in a low incidence country?
    • Trnka L, Daňková D, Krejbich F. Is quarterly cohort analysis useful for assessing treatment outcomes in a low incidence country? Int J Tuberc Lung Dis 2001;5:250-6.
    • (2001) Int J Tuberc Lung Dis , vol.5 , pp. 250-256
    • Trnka, L.1    Daňková, D.2    Krejbich, F.3
  • 17
    • 0011969005 scopus 로고    scopus 로고
    • Framework for effective tuberculosis control
    • WHO/TB/94
    • World Health Organization. Framework for effective tuberculosis control. WHO Document 1994; WHO/TB/94.179:5.
    • WHO Document 1994 , vol.179 , pp. 5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.